Invesco S&P MidCap 400 Pure Growth ETF Rating $59.41 -0.27 (-0.45%) Closing price 10/13/2026 04:10 PM EasternExtended Trading$59.40 -0.01 (-0.02%) As of 10/13/2026 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort Interest Invesco S&P MidCap 400 Pure Growth ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.RFG Aggregate RatingModerate Buy 2.72Holdings in RFG have an aggregate rating of Moderate Buy based on 333 analyst ratings issued in the past year covering 25 companies (43.5% of the portfolio).RFG Aggregate Price Target$59.41High Prediction$59.41Average Prediction$59.41Low Prediction$59.41Holdings in RFG have an aggregate price target of $59.41 and a range of $59.41 to $59.41 covering 25 companies (43.5% of the portfolio).RFG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco S&P MidCap 400 Pure Growth ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 RFG Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings2.67%HALOHalozyme Therapeutics$109.62-1.3%Moderate Buy$96.50 -12.0%123.2678 of 5 starsAnalyst Forecast2.37%TWLOTwilio$281.24-0.5%Moderate Buy$258.65 -8.0%282.7198 of 5 stars2.23%DOCNDigitalOcean$128.41-2.3%Moderate Buy$152.81 19.0%173.6606 of 5 starsAnalyst ForecastGap Down2.11%VICRVicor$267.24+3.0%Buy$391.67 46.6%54.3382 of 5 starsUpcoming EarningsAnalyst UpgradeGap Down2.07%FTITechnipFMC$70.63+1.3%Moderate Buy$74.92 6.1%143.8636 of 5 starsAnalyst Forecast1.94%STRLSterling Infrastructure$498.61-0.5%Moderate Buy$733.00 47.0%84.4847 of 5 stars1.91%IDCCInterDigital$332.88+1.4%Buy$450.00 35.2%43.7782 of 5 starsTrending NewsAnalyst Revision1.90%ARWRArrowhead Pharmaceuticals$58.13-4.3%Moderate Buy$98.31 69.1%142.4904 of 5 stars1.84%MEDPMedpace$609.89-1.6%Hold$607.73 -0.4%132.6649 of 5 stars1.74%CORTCorcept Therapeutics$117.80-2.8%Moderate Buy$138.17 17.3%83.8608 of 5 stars1.73%ATIATI$190.04+1.1%Buy$223.88 17.8%104.1007 of 5 stars1.69%WWDWoodward$332.500.0%Moderate Buy$418.36 25.8%134.3899 of 5 stars1.68%VALValaris$85.54+0.7%Reduce$67.80 -20.7%72.0378 of 5 stars1.65%FIVEFive Below$213.35-0.1%Moderate Buy$300.20 40.7%324.4569 of 5 starsAnalyst Upgrade1.64%CRSCarpenter Technology$380.38+0.8%Moderate Buy$526.88 38.5%104.9104 of 5 starsDividend AnnouncementAnalyst Downgrade1.60%RMBSRambus$98.17-2.8%Moderate Buy$145.88 48.6%104.5349 of 5 stars1.53%TTMITTM Technologies$116.10+5.2%Moderate Buy$204.75 76.4%64.524 of 5 starsTrending NewsAnalyst ForecastGap Down1.47%FCFSFirstCash$218.83+1.2%Moderate Buy$249.75 14.1%63.8529 of 5 stars1.46%EXELExelixis$59.51-0.5%Hold$50.79 -14.7%202.3312 of 5 starsAnalyst Revision1.44%IESCIES$280.04-2.7%Moderate Buy$334.50 19.4%32.3854 of 5 stars1.44%UTHRUnited Therapeutics$543.40-1.2%Moderate Buy$627.31 15.4%143.971 of 5 starsInsider Trade1.42%OKTAOkta$226.53-0.2%Moderate Buy$201.10 -11.2%432.8894 of 5 starsAnalyst Downgrade1.33%HLHecla Mining$16.17-4.0%Hold$23.34 44.4%104.2339 of 5 starsNews Coverage1.32%TLNTalen Energy$382.14+0.6%Moderate Buy$460.08 20.4%124.1133 of 5 starsGap Down1.30%KRYSKrystal Biotech$321.16-3.3%Buy$377.20 17.4%143.7005 of 5 stars This page (NYSEARCA:RFG) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredThis little-known gold fund distributes cash every FridayGold pays no dividends, no interest, no yield - it just sits there. Yet investors are reportedly collecting up...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredMy next big call (under $1)17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco S&P MidCap 400 Pure Growth ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco S&P MidCap 400 Pure Growth ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RFG Stock Alerts